Touyun Biotech Group Limited (1332.HK)
HKD 0.18
(-7.22%)
HKD 0.18
(-7.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 198.64 Million | 315.82 Million | 283.5 Million | 206.78 Million | 342.69 Million | 348.77 Million |
| Cost of Revenue | 142.03 Million | 195.7 Million | 176.45 Million | 122.17 Million | 217.2 Million | 254.09 Million |
| Gross Profit | 56.6 Million | 120.11 Million | 107.05 Million | 84.61 Million | 125.49 Million | 94.68 Million |
| Operating Expenses | 146.92 Million | 151.94 Million | 144.74 Million | 136.23 Million | 158.52 Million | 239.22 Million |
| Selling, General and Administrative Expenses | 124.63 Million | 154.68 Million | 144.74 Million | 139.2 Million | 158.52 Million | 239.35 Million |
| Research and Development Expenses | 22.29 Million | 20.28 Million | 21.93 Million | 20.86 Million | 17.3 Million | 33.33 Million |
| Other Expenses | - | -2.73 Million | 3.45 Million | -2.97 Million | 4.11 Million | -127 Thousand |
| Cost and Expenses | 288.95 Million | 347.65 Million | 321.19 Million | 258.4 Million | 375.72 Million | 493.31 Million |
| Operating Income | -90.31 Million | -26.54 Million | -35.3 Million | -73.17 Million | -122.81 Million | -147.13 Million |
| Interest Expense | 7.43 Million | 21.65 Million | 17.14 Million | 31.85 Million | 25.98 Million | 41.8 Million |
| Income Tax Expense | -16 Thousand | 3.47 Million | 971 Thousand | 6000.00 | 4.21 Million | 1.98 Million |
| Earnings before Tax | -272.58 Million | -199.18 Million | -122.97 Million | -171.98 Million | -194.89 Million | -251.97 Million |
| Net Income | -268.93 Million | -202.65 Million | -123.94 Million | -171.98 Million | -199.1 Million | -253.96 Million |
| Earnings Per Share Basic | -0.10 | -0.07 | -0.04 | -0.06 | -0.08 | -0.10 |
| Earnings Per Share Diluted | -0.10 | -0.07 | -0.04 | -0.06 | -0.08 | -0.10 |
| Weighted Average Shares Outstanding | 2.8 Billion | 2.8 Billion | 2.79 Billion | 2.67 Billion | 2.44 Billion | 2.44 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.8 Billion | 2.8 Billion | 2.79 Billion | 2.67 Billion | 2.44 Billion | 2.44 Billion |
| Gross Margin | 0.28 | 0.38 | 0.38 | 0.41 | 0.37 | 0.27 |
| EBIT Margin | -1.15 | 0.02 | -0.04 | -0.22 | -0.27 | -0.34 |
| Profit Margin | -1.35 | -0.64 | -0.44 | -0.83 | -0.58 | -0.73 |
| EBITDA | -228.56 Million | -144.39 Million | -83.12 Million | -87.22 Million | -197.68 Million | -181.66 Million |
| Earnings Before Tax Margin | -0.45 | -0.08 | -0.12 | -0.35 | -0.36 | -0.42 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 74.26 Million | 95.27 Million | 198.64 Million | 103.36 Million | 149.53 Million | 315.82 Million |
| Cost of Revenue | 41.95 Million | 73.59 Million | 142.03 Million | 68.43 Million | 87.98 Million | 195.7 Million |
| Gross Profit | 32.3 Million | 21.67 Million | 56.6 Million | 34.93 Million | 61.55 Million | 120.11 Million |
| Operating Expenses | 68.66 Million | 76.16 Million | 146.92 Million | 70.75 Million | 86.99 Million | 151.94 Million |
| Selling, General and Administrative Expenses | 68.66 Million | 76.16 Million | - | 70.75 Million | 86.99 Million | - |
| Research and Development Expenses | - | 22.29 Million | - | - | 21.2 Million | - |
| Other Expenses | - | - | 3.86 Million | - | - | -2.73 Million |
| Cost and Expenses | 110.62 Million | 149.76 Million | 288.95 Million | 139.19 Million | 174.97 Million | 347.65 Million |
| Operating Income | -36.36 Million | -54.49 Million | -90.31 Million | -35.82 Million | -25.44 Million | -26.54 Million |
| Interest Expense | 4.46 Million | 3.27 Million | 7.43 Million | 4.16 Million | 982 Thousand | 21.65 Million |
| Income Tax Expense | 326 Thousand | -38 Thousand | -16 Thousand | 22 Thousand | 1.52 Million | 3.47 Million |
| Earnings before Tax | -49.14 Million | -187.5 Million | -272.58 Million | -85.08 Million | -112.87 Million | -199.18 Million |
| Net Income | -47.96 Million | -184.98 Million | -268.93 Million | -83.95 Million | -109.99 Million | -202.65 Million |
| Earnings Per Share Basic | -0.02 | -0.07 | - | -0.03 | -0.04 | - |
| Earnings Per Share Diluted | -0.02 | -0.07 | - | -0.03 | -0.04 | - |
| Weighted Average Shares Outstanding | 2.8 Billion | 2.8 Billion | 2.8 Billion | 2.8 Billion | 2.8 Billion | 2.8 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.8 Billion | 2.8 Billion | 2.8 Billion | 2.8 Billion | 2.8 Billion | 2.8 Billion |
| Gross Margin | 0.44 | 0.23 | 0.28 | 0.34 | 0.41 | 0.38 |
| EBIT Margin | -0.37 | -0.30 | - | -0.24 | -0.04 | - |
| Profit Margin | -0.65 | -1.94 | -1.35 | -0.81 | -0.74 | -0.64 |
| EBITDA | -27.55 Million | -28.78 Million | - | -24.94 Million | -5.46 Million | - |
| Earnings Before Tax Margin | -0.49 | -0.57 | -0.45 | -0.35 | -0.17 | -0.08 |
8616
JEXYF
HOCPF
6227
DFILF
7957